24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
UroGen
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:11
Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes
17:56
Mobileye first quarter revenue falls by almost 50% as clients cut back on spending to clear excess stock
14:00
Melio names Boaz BenDavid as its first Chief Financial Officer
13:28
Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
Nvidia continues Israel shopping spree with acquisition of Deci
3
Nvidia announces $700 million acquisition of Run:ai
4
Nvidia on verge of completing $700 million acquisition of Run:ai
5
Nagomi Security raises $23 million Series A for proactive defense platform
More news
UroGen
5 stories about UroGen
”Exits are not a Strategy. I Never put up a ‘For Sale’ Sign”
23.05.20
|
Sophie Shulman and Golan Hazani
Arie Belldegrun, chairman of UroGen Pharma, talks about catching Covid-19 and gaining FDA approval in the midst of a global pandemic
Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen
24.04.19
|
CTech
The two companies will collaborate on the research of a “therapeutic area of mutual interest”
Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq
24.01.19
|
Lilach Baumer
Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering
Sustained Drug Release Company UroGen Submits New Drug Application to FDA
12.07.18
|
Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
Allergan Partners with Urine Incontinence Treatment Company
08.11.17
|
Lilach Baumer
Allergan is conducting clinical trials for a Botox-based bladder treatment, using a sustained release gel developed by Israel-based UroGen
Please ensure Javascript is enabled for purposes of
website accessibility